Accuracy of a Real-Time Continuous Glucose Monitor in Pediatric Diabetic Ketoacidosis Admissions
Diabetes Technology & Therapeutics · 2024-09 · 26 (9) · 626-632
DOI: 10.1089/dia.2023.0542 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes Technology & Therapeutics, online erschienen am 04.09.2024. Verfasst von Lauren A Waterman und 8 weiteren Autor:innen. Beteiligte Einrichtung: University of Colorado Anschutz Medical Campus, Barbara Davis Center for Diabetes, Aurora, Colorado, USA. Hauptthemen laut MEDLINE: Diabetic Ketoacidosis, Blood Glucose, Blood Glucose Self-Monitoring, Diabetes Mellitus, Type 1. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS.
Abstract (Originalsprache)
Objective
Continuous glucose monitoring (CGM) devices are integral in the outpatient care of people with type 1 diabetes, although they lack inpatient labeling. Food and Drug Administration began allowing inpatient use during the coronavirus disease 2019 (COVID-19) pandemic, with some accuracy data now available, primarily from adult hospitals. Pediatric inpatient data remain limited, particularly during diabetic ketoacidosis (DKA) admissions and for patients receiving intravenous (IV) insulin. Design and Methods: This retrospective chart review compared point-of-care glucose values to personal Dexcom G6 sensor data during pediatric hospitalizations. Accuracy was assessed using mean absolute relative difference (MARD), Clarke Error Grids, and the percentage of values within 15/20/30% if glucose value >100 mg/dL and 15/20/30 mg/dL if glucose value ≤100 mg/dL.
Results
Matched paired glucose values ( N = 612) from 36 patients (median age 14 years, 58.3% non-Hispanic White, 47.2% male) and 42 inpatient encounters were included in this subanalysis of DKA admissions. The MARDs for DKA and non-DKA admissions ( N = 503) were 11.8% and 11.7%, with 97.6% and 98.6% of pairs falling within A and B zones of the Clarke Error Grid, respectively. Severe DKA admissions (pH
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of Colorado Anschutz Medical Campus, Barbara Davis Center for Diabetes, Aurora, Colorado, USA.
- Department of Biostatistics and Informatics, Colorado School of Public Health, Aurora, Colorado, USA.
ORCID-Profile: Lauren A Waterman, Gregory P Forlenza, R Paul Wadwa, Erin C Cobry
Förderung
- NIDDK NIH HHS
Zitieren
APA
Waterman, L. A., Pyle, L., Forlenza, G. P., Towers, L., Karami, A. J., Jost, E., Berget, C., Wadwa, R. P., & Cobry, E. C. (2024). Accuracy of a Real-Time Continuous Glucose Monitor in Pediatric Diabetic Ketoacidosis Admissions. Diabetes Technology & Therapeutics, 26(9), 626-632. https://doi.org/10.1089/dia.2023.0542
Vancouver
Waterman LA, Pyle L, Forlenza GP, Towers L, Karami AJ, Jost E, et al. Accuracy of a Real-Time Continuous Glucose Monitor in Pediatric Diabetic Ketoacidosis Admissions. Diabetes Technology & Therapeutics. 2024;26(9):626-632. doi:10.1089/dia.2023.0542
BibTeX
@article{Waterman2024,
author = {Waterman, Lauren A and Pyle, Laura and Forlenza, Gregory P and Towers, Lindsey and Karami, Angela J and Jost, Emily and Berget, Cari and Wadwa, R Paul and Cobry, Erin C},
title = {Accuracy of a Real-Time Continuous Glucose Monitor in Pediatric Diabetic Ketoacidosis Admissions},
journal = {Diabetes Technology & Therapeutics},
year = {2024},
volume = {26},
number = {9},
pages = {626--632},
doi = {10.1089/dia.2023.0542}
}
EUVIMED